© 2004 BMJ Publishing Group Ltd & British Association of Sport and Exercise Medicine
ORIGINAL ARTICLE
Modification of plasma glycosaminoglycans in long distance runners
1 Department of Anatomy, Histology and Forensic Medicine, University of Firenze, Florence, Italy
2 Department of Experimental Pathology and Oncology, University of Firenze
3 Department of Biochemical Sciences, University of Firenze
Correspondence to:
Correspondence to:
Dr Pacini
Department of Anatomy, Histology and Forensic Medicine, University of Firenze, Viale Morgagni 85-50134, Florence 50134, Italy; stefania.pacini{at}unifi.it
Background: It is well documented that exercise reduces the risk of thromboembolic disease, possibly by increasing the plasma concentration of anticoagulant-antithrombotic compounds.
Objectives: As plasma glycosaminoglycans (GAGs) play a role in the anticoagulant-antithrombotic potential of plasma, to examine the concentration and profile of these compounds in well trained, long distance runners and sedentary subjects.
Methods: Plasma GAGs were measured in 10 male, long distance runners and 10 sedentary counterparts before and after ergometric tests. GAGs were extracted, purified, and identified by electrophoretic and enzymatic methods, and measured as hexosamine.
Results: Plasma GAGs found in sedentary subjects were slow migrating heparan sulphates I and II, keratan sulphate I, and chondroitin 46-sulphate. Those found in trained athletes were slow migrating heparan sulphate I, chondroitin 46-sulphate (or keratan sulphate I), and fast migrating heparan sulphate. Total plasma concentrations of GAGs were higher in athletes than in sedentary subjects at rest. In sedentary subjects, plasma GAGs did not change after cycle ergometric exercise at 80% of their anaerobic threshold. However, the appearance of a novel band of heparan sulphate migrating faster than fast migrating heparan sulphate was observed in athletes after exercise.
Conclusions: Exercise changes the amount and profile of plasma GAGs; these changes may play a role in protecting subjects who practise aerobic sports against developing cardiovascular disease.
Keywords: glycosaminoglycans; heparan sulphate; sedentary subjects; long distance runners; physical exercise
Abbreviations: GAG, glycosaminoglycan
Commentary
Universidade Federal do Rio de Janeiro, Departamento de Bioquimica, Caixa Postal 68041, Rio de Janeiro RJ 21941-500, Brazil; pmourao{at}hucff.ufrj.br
This article has been cited by other articles:
-
Myers, A. L., Upreti, V. V., Khurana, M., Eddington, N. D.
(2008). Characterization of Total Plasma Glycosaminoglycan Levels in Healthy Volunteers Following Oral Administration of a Novel Antithrombotic Odiparcil With Aspirin or Enoxaparin. J Clin Pharmacol
48: 1158-1170
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
